Emergence of omicron variant's sublineages BA.4 and BA.5: risks assessment and possible countermeasures by Manish Dhawan, AbdulRahman A. Saied, Talha Bin Emran, Om Prakash Choudhary

Subjects: Get full text

Application of nanomaterials against SARS-CoV-2: An emphasis on their usefulness against emerging variants of concern by Reema Iqbal, Reema Iqbal, Sadia Khan, Haroon Muhammad Ali, Maham Khan, Shahid Wahab, Tariq Khan

Subjects: Get full text

Increased Frequency of Indels in Hypervariable Regions of SARS-CoV-2 Proteins—A Possible Signature of Adaptive Selection by Arghavan Alisoltani, Lukasz Jaroszewski, Mallika Iyer, Arash Iranzadeh, Adam Godzik

Subjects: Get full text

Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern by Monika Kumari, Shih-Chieh Su, Kang-Hao Liang, Hsiu-Ting Lin, Yu-Feng Lu, Kai-Chi Chen, Wan-Yu Chen, Han-Chung Wu

Subjects: Get full text

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron by Alessio Mazzoni, Anna Vanni, Michele Spinicci, Michele Spinicci, Manuela Capone, Giulia Lamacchia, Lorenzo Salvati, Marco Coppi, Alberto Antonelli, Alberto Carnasciali, Parham Farahvachi, Nicla Giovacchini, Noemi Aiezza, Francesca Malentacchi, Lorenzo Zammarchi, Lorenzo Zammarchi, Francesco Liotta, Francesco Liotta, Francesco Liotta, Gian Maria Rossolini, Gian Maria Rossolini, Alessandro Bartoloni, Alessandro Bartoloni, Lorenzo Cosmi, Lorenzo Cosmi, Laura Maggi, Francesco Annunziato, Francesco Annunziato

Subjects: Get full text

Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor by Nishad Sultana, S. N. Nagesha, C. N. Lakshminarayana Reddy, B. N. Ramesh, S. Shyamalamma, K. S. Shashidhara, K. M. Satish, C. Pradeep, G. D Vidyadhar

Subjects: Get full text

Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern by Mahan Ghafari, Qihan Liu, Arushi Dhillon, Aris Katzourakis, Daniel B. Weissman

Subjects: Get full text

Corrigendum: Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern by Mahan Ghafari, Qihan Liu, Arushi Dhillon, Aris Katzourakis, Daniel B. Weissman

Subjects: Get full text

Development and performance of a point-of-care rapid antigen test for detection of SARS-COV-2 variants by Lihong Liu, Kathrine Meyers, Lawrence J. Purpura, Nadia Nguyen, Hiroshi Mohri, Jennifer Y. Chang, Medini K. Annavajhala, Leo Lopez, III, Sang Won Lee, Jayesh Shah, Benjamin Lane, Anyelina Cantos, Sade A. Tukuru, Yicheng Guo, Kenra Ford, Yueh-Ting Chiu, Zizhang Sheng, Tenzin Choesang, Delivette Castor, Maple Wang, Christina Pili, Michael N. Van Hoy, Andrew Wallach, Jamie Horton, Zhiqiang Chen, Susan Rosenthal, Son McLaren, Baowei Jiang, Frank Wang, Helen H. Lu, Anne-Catrin Uhlemann, David D. Ho, Michael T. Yin

Subjects: Get full text

SARS-CoV-2 Molecular Epidemiology Can Be Enhanced by Occupational Health: The Experience of Monitoring Variants of Concern in Workplaces in Rio de Janeiro, Brazil by Sergio N. Kuriyama, Sergio N. Kuriyama, Bruna Farjun, Bruna Farjun, Bianca Monteiro Henriques-Santos, Bianca Monteiro Henriques-Santos, Adriana Cabanelas, Adriana Cabanelas, Juliana Lourenço Abrantes, João Gesto, Antonio A. Fidalgo-Neto, Thiago Moreno L. Souza, Thiago Moreno L. Souza, Thiago Moreno L. Souza

Subjects: Get full text

SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility by Mariana Valério, Mariana Valério, Luís Borges-Araújo, Luís Borges-Araújo, Luís Borges-Araújo, Luís Borges-Araújo, Manuel N. Melo, Manuel N. Melo, Diana Lousa, Diana Lousa, Cláudio M. Soares, Cláudio M. Soares

Subjects: Get full text

Alpha, Beta, Delta, Omicron, and SARS-CoV-2 Breakthrough Cases: Defining Immunological Mechanisms for Vaccine Waning and Vaccine-Variant Mismatch by Benjamin Hewins, Benjamin Hewins, Motiur Rahman, Jesus F. Bermejo-Martin, Jesus F. Bermejo-Martin, Alyson A. Kelvin, Alyson A. Kelvin, Christopher D. Richardson, Salvatore Rubino, Anuj Kumar, Anuj Kumar, Pacifique Ndishimye, Pacifique Ndishimye, Ali Toloue Ostadgavahi, Ali Toloue Ostadgavahi, Abdullah Mahmud-Al-Rafat, Abdullah Mahmud-Al-Rafat, David J. Kelvin, David J. Kelvin

Subjects: Get full text

Tracking SARS-CoV-2 Variants Using a Rapid Typification Strategy: A Key Tool for Early Detection and Spread Investigation of Omicron in Argentina by Gonzalo M. Castro, Paola Sicilia, María Laura Bolzon, Laura Lopez, María Gabriela Barbás, María Belén Pisano, Viviana E. Ré

Subjects: Get full text

The Clinical Anatomy of SARS-CoV-2 Variants of Concern in Central Greece During October 2020–July 2022 by Ioanna Voulgaridi, Zacharoula Bogogiannidou, Katerina Dadouli, Achilleas P. Galanopoulos, Maria A. Kyritsi, Alexandros Vontas, Alexia Matziri, Konstantina Kola, Evangelia Vachtsioli, Lemonia Anagnostopoulos, Anastasia Tsispara, Katerina G. Oikonomou, Dimitris Babalis, Efthymia Petinaki, Maria Tseroni, Fani Kalala, Matthaios Speletas, Varvara A. Mouchtouri, Christos Hadjichristodoulou

Subjects: Get full text

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern by Qinhai Ma, Man Li, Lin Ma, Caroline Zhang, Hong Zhang, Huiling Zhong, Jian Wen, Yongsheng Wang, Zewei Yan, Wei Xiong, Linping Wu, Jianmin Guo, Wei Yang, Zifeng Yang, Zifeng Yang, Biliang Zhang, Biliang Zhang, Biliang Zhang

Subjects: Get full text

Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation by Karlijn van der Straten, Karlijn van der Straten, Marit J. van Gils, Steven W. de Taeye, Godelieve J. de Bree

Subjects: Get full text

Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study by Verena Schöning, Charlotte Kern, Charlotte Kern, Carlos Chaccour, Carlos Chaccour, Carlos Chaccour, Felix Hammann

Subjects: Get full text

A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects by Farokh Dotiwala, Arun K. Upadhyay

Subjects: Get full text

SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal... by Nina Reuter, Xiaohan Chen, Barbara Kropff, Antonia Sophia Peter, William J. Britt, Michael Mach, Klaus Überla, Marco Thomas

Subjects: Get full text

Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences by Reem Hoteit, Hadi M. Yassine

Subjects: Get full text